| 000 | 01552 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511191955.0 | ||
| 264 | 0 | _c19920422 | |
| 008 | 199204s 0 0 eng d | ||
| 022 | _a0902-4441 | ||
| 024 | 7 |
_a10.1111/j.1600-0609.1992.tb00568.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWisløff, F | |
| 245 | 0 | 0 |
_aBolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma. Nordic Myeloma Study Group (NMSG). _h[electronic resource] |
| 260 |
_bEuropean journal of haematology _cFeb 1992 |
||
| 300 |
_a70-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aGimsing, P | |
| 700 | 1 | _aHedenus, M | |
| 700 | 1 | _aHippe, E | |
| 700 | 1 | _aPalva, I | |
| 700 | 1 | _aTalstad, I | |
| 700 | 1 | _aTuresson, I | |
| 700 | 1 | _aWestin, J | |
| 773 | 0 |
_tEuropean journal of haematology _gvol. 48 _gno. 2 _gp. 70-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1992.tb00568.x _zAvailable from publisher's website |
| 999 |
_c1554361 _d1554361 |
||